Similar articles for PMID: 18954464

Year	Number of Results
1990	2
1991	1
1996	3
1997	4
1998	1
1999	1
2000	4
2001	4
2002	5
2003	5
2004	4
2005	3
2006	4
2007	4
2008	3
2009	6
2010	3
2011	4
2012	9
2013	5
2014	5
2015	6
2016	4
2017	5
2018	3
2019	2
2020	4
2021	1
2022	1
2023	2
2024	1

1

Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Ascierto PA, Kirkwood JM. Ascierto PA, et al. J Transl Med. 2008 Oct 27;6:62. doi: 10.1186/1479-5876-6-62. J Transl Med. 2008. PMID: 18954464 Free PMC article. Review.

2

Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis.

Ives NJ, Suciu S, Eggermont AMM, Kirkwood J, Lorigan P, Markovic SN, Garbe C, Wheatley K; International Melanoma Meta-Analysis Collaborative Group (IMMCG). Ives NJ, et al. Eur J Cancer. 2017 Sep;82:171-183. doi: 10.1016/j.ejca.2017.06.006. Epub 2017 Jul 7. Eur J Cancer. 2017. PMID: 28692949 Free article. Review.

3

Adjuvant interferon therapy for patients at high risk for recurrent melanoma: an updated systematic review and practice guideline.

Petrella T, Verma S, Spithoff K, Quirt I, McCready D; Melanoma Disease Site Group. Petrella T, et al. Clin Oncol (R Coll Radiol). 2012 Aug;24(6):413-23. doi: 10.1016/j.clon.2011.12.002. Epub 2012 Jan 13. Clin Oncol (R Coll Radiol). 2012. PMID: 22245520 Review.

4

The use of interferon in melanoma patients: a systematic review.

Di Trolio R, Simeone E, Di Lorenzo G, Buonerba C, Ascierto PA. Di Trolio R, et al. Cytokine Growth Factor Rev. 2015 Apr;26(2):203-12. doi: 10.1016/j.cytogfr.2014.11.008. Epub 2014 Nov 22. Cytokine Growth Factor Rev. 2015. PMID: 25511547 Review.

5

Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis.

Mocellin S, Pasquali S, Rossi CR, Nitti D. Mocellin S, et al. J Natl Cancer Inst. 2010 Apr 7;102(7):493-501. doi: 10.1093/jnci/djq009. Epub 2010 Feb 23. J Natl Cancer Inst. 2010. PMID: 20179267 Review.

6

Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

Suciu S, Eggermont AMM, Lorigan P, Kirkwood JM, Markovic SN, Garbe C, Cameron D, Kotapati S, Chen TT, Wheatley K, Ives N, de Schaetzen G, Efendi A, Buyse M. Suciu S, et al. J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx133. J Natl Cancer Inst. 2018. PMID: 28922786 Review.

7

Adjuvant treatment of malignant melanoma: where are we?

Ascierto PA, Scala S, Ottaiano A, Simeone E, de Michele I, Palmieri G, Castello G. Ascierto PA, et al. Crit Rev Oncol Hematol. 2006 Jan;57(1):45-52. doi: 10.1016/j.critrevonc.2005.05.002. Epub 2005 Jun 28. Crit Rev Oncol Hematol. 2006. PMID: 15990330 Review.

8

Interferons in melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Curr Opin Oncol. 1996 Mar;8(2):167-74. doi: 10.1097/00001622-199603000-00015. Curr Opin Oncol. 1996. PMID: 8727310 Review.

9

Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trials.

Malczewski A, Marshall A, Payne MJ, Mao L, Bafaloukos D, Si L, Pectasides D, Fountzilas G, Guo J, Gogas H, Middleton MR. Malczewski A, et al. Cancer Med. 2016 Jan;5(1):17-23. doi: 10.1002/cam4.563. Epub 2015 Dec 8. Cancer Med. 2016. PMID: 26645567 Free PMC article.

10

The future of Cochrane Neonatal.

Soll RF, Ovelman C, McGuire W. Soll RF, et al. Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year